Ram Yogev

13.0k total citations · 1 hit paper
298 papers, 9.1k citations indexed

About

Ram Yogev is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Ram Yogev has authored 298 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Epidemiology, 129 papers in Infectious Diseases and 65 papers in Virology. Recurrent topics in Ram Yogev's work include Pneumonia and Respiratory Infections (70 papers), HIV Research and Treatment (64 papers) and HIV/AIDS Research and Interventions (59 papers). Ram Yogev is often cited by papers focused on Pneumonia and Respiratory Infections (70 papers), HIV Research and Treatment (64 papers) and HIV/AIDS Research and Interventions (59 papers). Ram Yogev collaborates with scholars based in United States, South Africa and Thailand. Ram Yogev's co-authors include Sheldon L. Kaplan, Moshe Arditi, Tina Q. Tan, Stanford T. Shulman, Ellen R. Wald, William J. Barson, Edward O. Mason, Laurence B. Givner, Gordon E. Schutze and John S. Bradley and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ram Yogev

293 papers receiving 8.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphocyte subsets in healthy children from birth through 18 years of age

2003 560 citations Diane W. Wara, Katherine Luzuriaga et al. profile →

Peers

Countries citing papers authored by Ram Yogev

Since Specialization

Citations

This map shows the geographic impact of Ram Yogev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ram Yogev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ram Yogev more than expected).

Fields of papers citing papers by Ram Yogev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ram Yogev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ram Yogev. The network helps show where Ram Yogev may publish in the future.

Co-authorship network of co-authors of Ram Yogev

This figure shows the co-authorship network connecting the top 25 collaborators of Ram Yogev. A scholar is included among the top collaborators of Ram Yogev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ram Yogev. Ram Yogev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Live-Attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children 2020 ·American Journal of Respiratory and Critical Care Medicine ·Ruth A. Karron, Jessica E. Atwell, Elizabeth J. McFarland, Coleen K. Cunningham, Petronella Muresan, Charlotte Perlowski, (unknown), Stephen A. Spector, Ram Yogev, Mariam Aziz, Suzanne Woods, Kimberli Wanionek, Peter L. Collins, Ursula J. Buchholz	42
2	Effectiveness of Palivizumab in High-risk Infants and Children 2017 ·The Pediatric Infectious Disease Journal ·Evan J. Anderson, Phyllis Carosone‐Link, Ram Yogev, Jumi Yi, Eric A. F. Simões	62
3	Default Mode Connectivity in Youth With Perinatally Acquired HIV 2015 ·Medicine ·Megan M. Herting, Kristina A. Uban, Paige L. Williams, Prapti Gautam, Yanling Huo, Kathleen Malee, Ram Yogev, John G. Csernansky, Lei Wang, Sharon Nichols, Russell Van Dyke, Elizabeth R. Sowell	27
4	Safety and immunogenicity of a live attenuated intranasal vaccine against respiratory syncytial virus in healthy RSV seronegative children 5 to 24 months of age. 2013 ·PLoS ONE ·Elissa Malkin, Ram Yogev, Nazha Abughali, Joseph Sliman, (unknown), (unknown), C. Yang, (unknown), Mark T. Esser, Roderick S. Tang, Filip Dubovsky	6
5	A Chewable Pediatric Fixed-dose Combination Tablet of Stavudine, Lamivudine, and Nevirapine 2010 ·The Pediatric Infectious Disease Journal ·Nirun Vanprapar, Tim R. Cressey, Kulkanya Chokephaibulkit, Petronella Muresan, Nottasorn Plipat, Virat Sirisanthana, Wasana Prasitsuebsai, (unknown), Tawee Chotpitayasunondh, (unknown), (unknown), Mary E. Smith, Kenneth McIntosh, Edmund V. Capparelli, Ram Yogev	28
6	Planned Multiple Exposures to Autologous Virus in HIV Type 1-Infected Pediatric Populations Increases HIV-Specific Immunity and Reduces HIV Viremia 2008 ·AIDS Research and Human Retroviruses ·William Borkowsky, Ram Yogev, Petronella Muresan, Elizabeth J. McFarland, Lisa M. Frenkel, Terry Fenton, Edmund V. Capparelli, Jack Moye, Paul A. Harding, (unknown), Barbara Heckman, Joyce Kraimer	9
7	A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children 2006 ·PEDIATRICS ·Molly L. Nozyce, (unknown), Andrew Wiznia, Sharon Nachman, Lynne Mofenson, Mary E. Smith, Ram Yogev, Kenneth McIntosh, Kenneth Stanley, Stephen I. Pelton	139
8	Linezolid for the treatment of complicated skin and skin structure infections in children 2003 ·The Pediatric Infectious Disease Journal ·Ram Yogev, L. E. R. Patterson, Sheldon L. Kaplan, Stuart P. Adler, (unknown), (unknown), (unknown), SHARON NABERHUIS-STEHOUWER, Jon Bruss	42
9	Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced children with human immunodeficiency virus infection 2002 ·The Pediatric Infectious Disease Journal ·Ram Yogev, Sophia Lee, Andrew Wiznia, Sharon Nachman, Kenneth Stanley, Stephen I. Pelton, Lynne Mofenson, Susan A. Fiscus, Eleanor Jiménez, Mobeen H. Rathore, Mary E. Smith, Lin Song, Kenneth McIntosh	6
10	Six year multicenter surveillance of invasive pneumococcal infections in children 2002 ·The Pediatric Infectious Disease Journal ·Sheldon L. Kaplan, Edward O. Mason, Ellen R. Wald, Tina Q. Tan, Gordon E. Schutze, John S. Bradley, Laurence B. Givner, Kwang Sik Kim, Ram Yogev, William J. Barson	100
11	Invasive pneumococcal infections in children with asplenia 2002 ·The Pediatric Infectious Disease Journal ·Gordon E. Schutze, Edward O. Mason, William J. Barson, Kwang Sik Kim, Ellen R. Wald, Laurence B. Givner, Tina Q. Tan, John S. Bradley, Ram Yogev, Sheldon L. Kaplan	64
12	Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriaxone in children treated with beta-lactam antibiotics 2001 ·The Pediatric Infectious Disease Journal ·Sheldon L. Kaplan, Edward O. Mason, William J. Barson, Tina Q. Tan, Gordon E. Schutze, John S. Bradley, Laurence B. Givner, Kwang Sik Kim, Ram Yogev, Ellen R. Wald	33
13	Infrequent Detection of HIV-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Cell Responses in Young HIV-1-Infected Infants 2001 ·The Journal of Immunology ·Zachary Scott, Ellen G. Chadwick, Laura Gibson, Michelle D. Catalina, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga, (unknown)	57
14	Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus 1999 ·The Pediatric Infectious Disease Journal ·Kenneth McIntosh, Ellen Cooper, Jing Xu, Mark Mirochnick, Jane C. Lindsey, David P. Jacobus, Lynne Mofenson, Ram Yogev, Stephen A. Spector, John L. Sullivan, Henry S. Sacks, Andrea Kovács, Sharon Nachman, John W. Sleasman, Vincent R. Bonagura, James McNamara	13
15	Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and Children 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·John S. Lambert, James McNamara, Samuel L. Katz, Terry Fenton, Minhee Kang, Thomas C. VanCott, Robert A. Livingston, Elizabeth Hawkins, Jack Moye, William Borkowsky, Daniel Johnson, Ram Yogev, (unknown), (unknown), Anne A. Gershon, Diane W. Wara, (unknown), Myron J. Levin, George McSherry, Gale Smith	25
16	Update on tuberculosis skin testing of children 1996 ·PEDIATRICS ·N. A. Halsey, P. Joan Chesney, (unknown), Donald S. Gromisch, Schuyler G. Kohl, S. Michael Marcy, Melvin I. Marks, Dennis L. Murray, James C. Overall, Larry K. Pickering, Ronald J. Whitley, Ram Yogev	36
17	Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections 1996 ·PEDIATRICS ·N. A. Halsey, P. Joan Chesney, Michael A. Gerber, Donald S. Gromisch, Steve Kohl, S. Michael Marcy, Melvin I. Marks, Dennis L. Murray, James C. Overall, Larry K. Pickering, R. J. Whitley, Ram Yogev, (unknown), Ruth L. Berkelman, (unknown), R F Jacobs, Noni E. MacDonald, Walter A. Orenstein, N. Regina Rabinovich	113
18	Screening for tuberculosis in infants and children 1994 ·PEDIATRICS ·Charles B. Hall, Dan M. Granoff, Donald S. Gromisch, N. A. Halsey, Schuyler G. Kohl, Edgar K. Marcuse, Melvin I. Marks, G. A. Nankervis, Larry K. Pickering, G. B. Scott, Russell W. Steele, Ram Yogev	56
19	The use of oral acyclovir in otherwise healthy children with varicella 1993 ·PEDIATRICS ·C. B. Hall, Dan M. Granoff, Donald S. Gromisch, N. A. Halsey, Steve Kohl, Edgar K. Marcuse, Melvin I. Marks, G. A. Nankervis, Larry K. Pickering, G. B. Scott, R.W. Steele, Ram Yogev, G Péter, K. J. Bart, C. V. Broome, M. C. Hardegree, R. F. Jacobs, NE MacDonald, Walter A. Orenstein, (unknown)	47
20	Intraventricular levels of amikacin after intravenous administration 1980 ·Pediatric Research ·Ram Yogev, William M. Kolling	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact